CHINA BIOLOGIC PRODS INC's ticker is CBPOXXXX and the CUSIP is 16938C106. A total of 133 filers reported holding CHINA BIOLOGIC PRODS INC in Q1 2016. The put-call ratio across all filers is 0.86 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $535,000 | +133.6% | 4,300 | +115.0% | 0.06% | +75.0% |
| Q1 2016 | $229,000 | +252.3% | 2,000 | +195.4% | 0.03% | +255.6% |
| Q1 2015 | $65,000 | -4.4% | 677 | -32.9% | 0.01% | -10.0% |
| Q4 2014 | $68,000 | +25.9% | 1,009 | +0.9% | 0.01% | +25.0% |
| Q3 2014 | $54,000 | +315.4% | 1,000 | +233.3% | 0.01% | +300.0% |
| Q2 2014 | $13,000 | -85.1% | 300 | -88.1% | 0.00% | -83.3% |
| Q1 2014 | $87,000 | – | 2,516 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WARBURG PINCUS LLC | 8,344,200 | $960,918,000 | 7.67% |
| RUDMAN ERROL M | 130,201 | $14,994,000 | 5.06% |
| Ativo Capital Management LLC | 59,101 | $7,258,000 | 2.56% |
| Kylin Management | 188,226 | $21,676,000 | 2.36% |
| Monashee Investment Management LLC | 40,000 | $4,606,000 | 2.17% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 62,866 | $7,240,000 | 1.91% |
| Cormorant Asset Management, LP | 111,500 | $12,840,000 | 1.71% |
| OBERWEIS ASSET MANAGEMENT INC/ | 53,500 | $6,161,000 | 1.63% |
| Perceptive Advisors | 147,604 | $16,998,000 | 1.02% |
| Granite Point Capital Management, L.P. | 29,160 | $3,358,000 | 0.98% |